Literature DB >> 21577628

trans-Ethyl-enedi-p-phenyl-ene diacetate.

Stefanie Ritter1, Jörg-M Neudörfl, Janna Velder, Hans-Günther Schmalz.   

Abstract

The centrosymmetric title compound, C(18)H(26)O(4), was prepared in high yield from 4-acetoxy-styrene via Ru-catalysed homo-olefin metathesis. Exclusive formation of the E-configurated isomer was observed. In the crystal, a strong C-H⋯π inter-molecular inter-action links the mol-ecules together.

Entities:  

Year:  2009        PMID: 21577628      PMCID: PMC2970084          DOI: 10.1107/S1600536809032620

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the preparation of differently substituted stilbenes using a Ru-catalysed metathesis strategy, see: Velder et al. (2006 ▶). For alternative methodologies for the synthesis of ­oxy-functionalized stilbenes using Wittig-type olefinations or Heck-couplings, see: Kim et al. (2002 ▶); Lion et al. (2005 ▶); Botella et al. (2004 ▶); Reetz et al. (1998 ▶). For the bioactivity of various stilbenes with a focus on their anti­cancer activity, see: Aggarwal et al. (2004 ▶); Wolter et al. (2002 ▶); Fremont (2000 ▶); Jang et al. (1997 ▶); Wieder et al. (2001 ▶). For related structures see: Malone et al. (1997 ▶). For a previous synthesis of the title compound see: Johnson et al. (1952 ▶).

Experimental

Crystal data

C18H16O4 M = 296.31 Monoclinic, a = 9.7430 (4) Å b = 7.2839 (4) Å c = 11.2723 (6) Å β = 113.649 (3)° V = 732.78 (7) Å3 Z = 2 Mo Kα radiation μ = 0.10 mm−1 T = 100 K 0.52 × 0.36 × 0.34 mm

Data collection

Nonius KappaCCD diffractometer Absorption correction: none 3533 measured reflections 1595 independent reflections 1119 reflections with I > 2σ(I) R int = 0.038

Refinement

R[F 2 > 2σ(F 2)] = 0.042 wR(F 2) = 0.106 S = 1.03 1595 reflections 101 parameters H-atom parameters constrained Δρmax = 0.20 e Å−3 Δρmin = −0.21 e Å−3 Data collection: COLLECT (Hooft, 1998 ▶); cell refinement: DENZO (Otwinowski & Minor, 1997 ▶); data reduction: DENZO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SCHAKAL99 (Keller, 1999 ▶); software used to prepare material for publication: PLATON (Spek, 2009 ▶) and enCIFer (Allen et al., 2004 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536809032620/hg2554sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809032620/hg2554Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C18H16O4F(000) = 312
Mr = 296.31Dx = 1.343 Mg m3
Monoclinic, P21/cMelting point: 214 K
Hall symbol: -P 2ybcMo Kα radiation, λ = 0.71073 Å
a = 9.7430 (4) ÅCell parameters from 3533 reflections
b = 7.2839 (4) Åθ = 2.3–27.0°
c = 11.2723 (6) ŵ = 0.10 mm1
β = 113.649 (3)°T = 100 K
V = 732.78 (7) Å3Needle, colourless
Z = 20.52 × 0.36 × 0.34 mm
Nonius KappaCCD diffractometer1119 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.038
graphiteθmax = 27.0°, θmin = 2.3°
φ and ω scansh = −12→12
3533 measured reflectionsk = −8→9
1595 independent reflectionsl = −14→14
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.042Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.106H-atom parameters constrained
S = 1.02w = 1/[σ2(Fo2) + (0.0486P)2 + 0.0561P] where P = (Fo2 + 2Fc2)/3
1595 reflections(Δ/σ)max = 0.002
101 parametersΔρmax = 0.20 e Å3
0 restraintsΔρmin = −0.21 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. The coordinates of the hydrogen atoms are constrained, and the U values of the H atoms are constrained relative to the Ueq of the atom the hydrogen binds to (1.2 for CH and CH2, 1.5 for CH3).
xyzUiso*/Ueq
O10.26496 (12)0.47976 (14)0.58904 (9)0.0210 (3)
O20.37476 (12)0.75603 (15)0.60504 (10)0.0249 (3)
C10.06877 (16)0.48067 (19)0.04361 (14)0.0165 (3)
H10.14120.44660.01110.020*
C20.11855 (16)0.48580 (19)0.18473 (14)0.0151 (3)
C30.25433 (16)0.4033 (2)0.26319 (14)0.0171 (3)
H30.31340.34680.22380.020*
C40.30488 (16)0.4019 (2)0.39715 (14)0.0176 (3)
H40.39710.34460.44920.021*
C50.21842 (17)0.4853 (2)0.45310 (13)0.0165 (4)
C60.08410 (17)0.5691 (2)0.37923 (14)0.0189 (4)
H60.02610.62590.41950.023*
C70.03502 (17)0.5694 (2)0.24605 (14)0.0179 (4)
H7−0.05720.62740.19500.021*
C80.34023 (17)0.6307 (2)0.65644 (15)0.0187 (4)
C90.37163 (18)0.6128 (2)0.79670 (14)0.0245 (4)
H9A0.42100.72450.84240.037*
H9B0.43730.50700.83300.037*
H9C0.27730.59510.80690.037*
U11U22U33U12U13U23
O10.0304 (7)0.0177 (6)0.0123 (6)−0.0031 (5)0.0058 (5)−0.0012 (4)
O20.0264 (7)0.0227 (6)0.0258 (6)−0.0058 (5)0.0106 (5)−0.0025 (5)
C10.0191 (8)0.0139 (8)0.0174 (8)−0.0008 (6)0.0083 (6)−0.0011 (6)
C20.0168 (8)0.0117 (7)0.0154 (8)−0.0031 (6)0.0051 (6)0.0008 (6)
C30.0184 (8)0.0156 (8)0.0175 (8)−0.0012 (6)0.0076 (7)−0.0019 (6)
C40.0156 (8)0.0154 (8)0.0181 (8)−0.0004 (6)0.0027 (6)0.0013 (6)
C50.0239 (9)0.0132 (8)0.0106 (8)−0.0049 (6)0.0049 (7)−0.0005 (6)
C60.0245 (9)0.0145 (8)0.0192 (8)0.0008 (6)0.0102 (7)−0.0023 (6)
C70.0198 (9)0.0152 (8)0.0169 (8)0.0018 (6)0.0055 (7)0.0010 (6)
C80.0146 (8)0.0187 (9)0.0212 (8)0.0035 (6)0.0056 (7)−0.0039 (7)
C90.0275 (9)0.0245 (9)0.0174 (9)0.0029 (7)0.0046 (7)−0.0037 (7)
O1—C81.3700 (18)C4—C51.380 (2)
O1—C51.4135 (16)C4—H40.9500
O2—C81.1994 (17)C5—C61.380 (2)
C1—C1i1.336 (3)C6—C71.381 (2)
C1—C21.466 (2)C6—H60.9500
C1—H10.9500C7—H70.9500
C2—C31.398 (2)C8—C91.491 (2)
C2—C71.401 (2)C9—H9A0.9800
C3—C41.388 (2)C9—H9B0.9800
C3—H30.9500C9—H9C0.9800
C8—O1—C5116.48 (11)C5—C6—C7119.19 (14)
C1i—C1—C2126.23 (17)C5—C6—H6120.4
C1i—C1—H1116.9C7—C6—H6120.4
C2—C1—H1116.9C6—C7—C2121.30 (14)
C3—C2—C7117.66 (14)C6—C7—H7119.3
C3—C2—C1119.52 (13)C2—C7—H7119.3
C7—C2—C1122.81 (13)O2—C8—O1122.30 (14)
C4—C3—C2121.62 (14)O2—C8—C9126.94 (14)
C4—C3—H3119.2O1—C8—C9110.76 (13)
C2—C3—H3119.2C8—C9—H9A109.5
C5—C4—C3118.61 (14)C8—C9—H9B109.5
C5—C4—H4120.7H9A—C9—H9B109.5
C3—C4—H4120.7C8—C9—H9C109.5
C4—C5—C6121.62 (13)H9A—C9—H9C109.5
C4—C5—O1119.59 (13)H9B—C9—H9C109.5
C6—C5—O1118.75 (13)
C1i—C1—C2—C3165.70 (18)C8—O1—C5—C6−85.05 (16)
C1i—C1—C2—C7−13.8 (3)C4—C5—C6—C70.0 (2)
C7—C2—C3—C40.6 (2)O1—C5—C6—C7−177.66 (13)
C1—C2—C3—C4−178.87 (13)C5—C6—C7—C20.3 (2)
C2—C3—C4—C5−0.4 (2)C3—C2—C7—C6−0.6 (2)
C3—C4—C5—C60.1 (2)C1—C2—C7—C6178.93 (13)
C3—C4—C5—O1177.71 (12)C5—O1—C8—O2−5.1 (2)
C8—O1—C5—C497.22 (15)C5—O1—C8—C9175.46 (12)
D—H···AD—HH···AD···AD—H···A
C7—H7···Cg1ii0.952.813.539 (2)135
Table 1

Geometry the C—H⋯π interaction (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C7—H7⋯Cg1i0.952.813.539 (2)135

Symmetry code: (i) . Cg1 is the centroid of the C2–C7 ring.

  8 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes.

Authors:  Cedric J Lion; Charles S Matthews; Malcolm F G Stevens; Andrew D Westwell
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

3.  Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.

Authors:  Sanghee Kim; Hyojin Ko; Jae Eun Park; Sungkyu Jung; Sang Kwang Lee; Young-Jin Chun
Journal:  J Med Chem       Date:  2002-01-03       Impact factor: 7.446

Review 4.  Biological effects of resveratrol.

Authors:  L Frémont
Journal:  Life Sci       Date:  2000-01-14       Impact factor: 5.037

5.  Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts.

Authors:  T Wieder; A Prokop; B Bagci; F Essmann; D Bernicke; K Schulze-Osthoff; B Dörken; H G Schmalz; P T Daniel; G Henze
Journal:  Leukemia       Date:  2001-11       Impact factor: 11.528

6.  Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.

Authors:  M Jang; L Cai; G O Udeani; K V Slowing; C F Thomas; C W Beecher; H H Fong; N R Farnsworth; A D Kinghorn; R G Mehta; R C Moon; J M Pezzuto
Journal:  Science       Date:  1997-01-10       Impact factor: 47.728

Review 7.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

Authors:  Bharat B Aggarwal; Anjana Bhardwaj; Rishi S Aggarwal; Navindra P Seeram; Shishir Shishodia; Yasunari Takada
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

8.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.